PMS38 COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB SC IN COMPARISON WITH ANAKINRA IN SYSTEMIC IDIOPATHIC JUVENILE ARTHRITIS (SJIA) TREATMENT IN TURKEY
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1582
https://www.valueinhealthjournal.com/article/S1098-3015(19)33960-9/fulltext
Title :
PMS38 COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB SC IN COMPARISON WITH ANAKINRA IN SYSTEMIC IDIOPATHIC JUVENILE ARTHRITIS (SJIA) TREATMENT IN TURKEY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33960-9&doi=10.1016/j.jval.2019.09.1582
First page :
Section Title :
Open access? :
No
Section Order :
11369